Proveris Scientific expands research team with the addition of accomplished research scientist, Prateek Nath, Ph.D.

Proveris Scientific Corporation, a leading provider of instrumentation and services to advance the science of aerosol and spray products, today announced Prateek Nath has joined as a research scientist in Proveris Scientific’s growing research team.

 

Prateek will perform a range of research activities to advance new technology platforms at Proveris. His focus will be to design and build a wide variety of research-grade prototypes and run experiments on these prototypes to generate proof statements for scientific hypotheses related to aerosol science, human physiology, and drug delivery. In addition, Prateek will actively participate in Proveris’s research collaborations with academic, industrial, and government organizations. 

Prateek holds a Ph.D. in solid mechanics and minors in applied mathematics and materials science from Brown University in Providence, Rhode Island. He earned his Master of Science in mechanical design and optimization from Indian Institute of Technology, Bombay, India, and his Bachelor of Science in mechanical engineering from University of Pune. Prior to joining Proveris, Prateek worked as a computational modeling engineer for Johnson and Johnson in Raynham, Massachusetts, as a research engineer for Bose Corporation in Framingham, Massachusetts, and as a postdoctoral research fellow for Oak Ridge National Laboratory in Oak Ridge, Tennessee. Prateek holds nine U.S. Patents and has authored multiple publications and conference presentations.

Proveris Scientific’s Founder and CEO, Dino Farina, commented, “I’m excited to have Prateek join the Proveris team. Prateek’s significant engineering experience from Oak Ridge National Laboratory, Bose Corporation, and J&J are perfect complements to Proveris’s advanced research focus on integrating human physiology, aerosol science, and drug delivery into better tools for predictive performance modeling of orally inhaled and nasal drug products.”

 

About Proveris Scientific

Proveris Scientific Corporation advances the science of respiratory drug delivery products by driving new technology development for high performance spray characterization, capture, and analysis, while leveraging its expertise, experience, and core technologies. With customer success as its central motivating force, Proveris Scientific adds value to a global customer base with “complete solutions” which include product innovation, technical services, systems, consumables, and educational training. Since its founding in 1995, the company has accelerated the development of top spray and aerosol drug products and has deployed its systems at more than 100 pharmaceutical development and manufacturing sites around the globe. Proveris’s systems are the industry standard and are used by the FDA, CFDA, and the pharmaceutical industry to generate submission-ready data. Proveris is certified to ISO 9001:2015 by TÜV Rheinland of North America, Inc., and has more than 20 patents issued on its technology.

Maria Smith appointed as Director, Application and Business Development for Proveris Laboratories

Proveris Scientific Corporation, a leading provider of instrumentation and services to advance the science of aerosol and spray products, today announced the appointment of Maria L. Smith, M.Sc., to the newly established role of Director, Application and Business Development for Proveris Laboratories. This is a new position focused on addressing the rapid growth of the cGMP contract test services and the introduction of new technologies. 

Maria joins Proveris with more than 14 years of CDMO experience in the development and test of orally inhaled and nasal drug products (OINDPs). She has extensive experience in spray characterization, as well as working with customers on problem resolution and compliance. She has authored 10 publications on spray characterization and is well known across the industry for her professionalism, experience, and expertise.

Maria will help drive the growth of Proveris Laboratories contract test services through the expansion of new applications and technologies. In addition, she will serve as a liaison to regulatory agencies, industry groups, and customers to educate on new technology approaches and how they can be used to support in-vitro in-vivo correlation (IVIVC) and bioequivalence (BE).   

Proveris Scientific’s President, Chip Leveille, commented, “Maria’s fourteen years of laboratory experience in spray/particulate science (nasal and oral products) with leading CDMO’s brings a deep understanding of drug development and testing as it pertains to inhalation products. She has extensive knowledge of Proveris systems and particle characterization techniques to develop and characterize aerosol and spray delivered drug devices. We are excited to have Maria on board to further establish and enhance Proveris technologies as critical approaches to drug approval and product release.”

 

About Proveris Scientific

Proveris Scientific Corporation advances the science of respiratory drug delivery products by driving new technology development for high performance spray characterization, capture, and analysis, while leveraging its expertise, experience, and core technologies. With customer success as its central motivating force, Proveris Scientific adds value to a global customer base with “complete solutions” which include product innovation, technical services, systems, consumables, and educational training. Since its founding in 1995, the company has accelerated the development of top spray and aerosol drug products and has deployed its systems at more than 100 pharmaceutical development and manufacturing sites around the globe. Proveris’s systems are the industry standard and are used by the FDA, CFDA, and the pharmaceutical industry to generate submission-ready data. Proveris is certified to ISO 9001:2015 by TÜV Rheinland of North America, Inc., and has more than 20 patents issued on its technology.

Proveris Laboratories announces expanded services for spray and aerosol characterization of unit-dose nasal drugs

Proveris Scientific Corporation, a leading provider of instrumentation and services to advance the science of aerosol and spray products, today announced the expansion of contract test services for product characterization, performance, safety, and bioequivalence testing of unit-dose nasal drugs.

Utilizing optimized hardware, Proveris Laboratories now offers the ability to perform in vitro characterization testing on unit-dose devices at multiple orientations, allowing developers to test products designed to be administered in a prone position by a physician, first responder, or caregiver. These new service offerings allow developers to not only comply with regulatory guidance, but also gain key insights early in the development process, with regards to device performance.

Proveris Scientific’s other patented technologies and methodologies allow for robust evaluation of unit-dose spray pumps, syringes, pressurized aerosol devices, and both liquid and powder formulations intended for systemic, nose-to-brain, and local delivery. cGMP-compliant and non-GMP test services include predictive modeling experiments using the Proveris by Design™ design of experiments (DoE) method, human actuation studies using Ergo™ technology, and product characterization studies performed on industry gold standard SprayVIEW® Measurement Systems. Vereo® Automated Actuators, which are at the center of most Proveris platforms, are powered by Viota® Software, including unit-dose capability to allow for proper actuation of single shot devices that often require specially tailored profiles to deliver the full dose. 

Alberto Correia, Vice President of Technical Services and Proveris Laboratories commented, “Developers of intranasal branded and generic drugs for the treatment of conditions such as drug overdose reversal and seizures will benefit from Proveris’s simple and precise setup to be able to test their products in multiple orientations, mimicking how these products will actually be administered in real-life situations. Additionally, the unit-dose configuration in our Viota software allows each device to be actuated properly using a force limited methodology ensuring full dose delivery. Force profiles generated from each actuation can help to confirm dose delivery. This is critical for unit dose devices designed for use in combatting life-threatening events such as drug overdose and seizures, as well as for potent drugs where exceeding the dosage limit is dangerous.”

About Proveris Scientific

Proveris Scientific Corporation advances the science of respiratory drug delivery products by driving new technology development for high performance spray characterization, capture, and analysis, while leveraging its expertise, experience, and core technologies. With customer success as its central motivating force, Proveris Scientific adds value to a global customer base with “complete solutions” which include product innovation, technical services, systems, consumables, and educational training. Since its founding in 1995, the company has accelerated the development of top spray and aerosol drug products and has deployed its systems at more than 100 pharmaceutical development and manufacturing sites around the globe. Proveris’s systems are the industry standard and are used by the FDA, CFDA, and the pharmaceutical industry to generate submission-ready data. Proveris is certified to ISO 9001:2015 by TUV Rheinland of North America, Inc., and has more than 20 patents issued on its technology.

Lynn Jordan joins Proveris as Applications Laboratory Manager

Proveris Scientific Corporation, a leading provider of services and technology to advance the science of spray and aerosol products, today announced that experienced life sciences professional Lynn Jordan has joined Proveris as Applications Laboratory Manager.

Lynn joins Proveris with more 25 years of experience in applications and bioanalytical science, laboratory services management, and technical sales at life science technology and instrumentation providers, including:  New England Nuclear, Amicon, Zymark, Waters Corporation, Perkin Elmer, and Biotage. Lynn has a reputation as a strong leader and accomplished scientist with expertise in the introduction of new assays and technologies for sample preparation, analysis, and automation in the life sciences.

In her role at Proveris, Lynn will lead the fulfillment of contract test services, working collaboratively with field sales to meet and exceed technical support standards and customer expectations. Lynn will also play an integral role in product development and R&D projects, adding a customer perspective to the functional specifications. In addition, she will contribute to the development of promotional materials, seminars, and workshop presentations.

Lynn is the author of four publications and contributed to a chapter in “Automated Solid Phase Extraction,” published by Marcel Dekker. Lynn has a bachelor’s degree in Chemistry from Russel Sage College and has completed master’s course work in Separations Sciences from Rensselaer Polytechnical Institute.

 

About Proveris Scientific

Proveris Scientific Corporation advances the science of respiratory drug delivery products by driving new technology development for high performance spray characterization, capture, and analysis, while leveraging its expertise, experience, and core technologies. With customer success as its central motivating force, Proveris Scientific adds value to a global customer base with “complete solutions” which include product innovation, technical services, systems, consumables, and educational training. Since its founding in 1995, the company has accelerated the development of top spray and aerosol drug products and has deployed its systems at more than 100 pharmaceutical development and manufacturing sites around the globe. Proveris’s systems are the industry standard and are used by the pharmaceutical industry to generate submission-ready data and regulatory agencies such as the US FDA and China NMPA (National Medical Products Administration). Proveris is certified to ISO 9001:2015 by TUV Rheinland of North America, Inc., and has more than 20 patents issued on its technology.

Research Collaboration: Next Generation Technologies for Improving the Measurement of Pharmaceutical Aerosols

Proveris Scientific Corporation, a leading provider of instrumentation and services to advance the science of aerosol and spray products, today announced its research collaboration with The University of Sydney and Macquarie University on a project to develop a new generation of measurement technologies for improving the measurement of pharmaceutical aerosols.

The project aims to develop an innovative optical tomography technology capable of direct and real-time measurement of the surface area of airborne particles. By coupling advanced laser diagnostic tools with physiological models and in vitro characterization techniques, the research team will investigate critical relationships between the surface area of an aerosol and its dissolution when delivered to a target. The outcomes will enable aerosol device manufacturers to develop and market more advanced and highly specific products.

The concept, originally conceived by Proveris Scientific, is to significantly enhance the characterization of inhaled aerosols with respect to their potential bioavailability or toxicity. Mr. Dino Farina, Partner Investigator, Proveris Scientific Corporation, Professor Hak-Kim Chan, Chief Investigator from the School of Pharmacy at The University of Sydney, and Dr. Agisilaos Kourmatzis, Chief Investigator from the School of Aerospace, Mechanical, and Mechatronic Engineering at The University of Sydney collaborated on a research plan. The multi-year research collaboration is funded by the Australian Research Council Linkage Program which promotes national and international research partnerships between researchers and business, industry, community organizations, and other publicly funded research agencies. As the administering organizing, Professor Chan and Dr. Kourmatzis also invited Dr. Shaokoon Cheng, Chief Investigator, Macquarie University, as a collaborator on the project.

Dr. Kourmatzis commented, “To me, partnering with Proveris means partnering with an organization who understand that engineering innovation, multidisciplinary research, and the highest quality R&D driven by solid science is what leads to positive changes to people’s lives. As an engineer, I am really excited to work on this project and look forward to a deep engagement which can lead to a long-lasting impact on the aerosols industry.”

Professor Hak-Kim Chan stated, “We are really thrilled to have this excellent opportunity  conducting joint R&D with Proveris in developing a novel technology platform that can shift the paradigm in the field. This project marks the beginning of a long-term relationship with Proveris to maximize mutual beneficial outcomes through strategic collaboration.”

Dr Shaokoon Cheng added, “It is really exciting to work with Proveris in developing a device that could transform how things are currently being measured in the pharmaceutical industries. These engagements are critical to improving the efficiency of work processes that I believe will bring enormous economic benefits to companies.”

Dino Farina concluded, “Significantly enhancing comparative in vivo results utilizing predictive in-vitro technologies for inhaled aerosol characterization is a critical need in providing safer and more efficacious drugs to patients worldwide. Having the ability to work with these three top researchers on this new technology is exciting and will result in technology that will advance inhalation science and help make it a more effective route for drug delivery.”

About Proveris Scientific

Proveris Scientific Corporation advances the science of respiratory drug delivery products by driving new technology development for high performance spray characterization, capture, and analysis, while leveraging its expertise, experience, and core technologies. With customer success as its central motivating force, Proveris Scientific adds value to a global customer base with “complete solutions” which include product innovation, technical services, systems, consumables, and educational training. Since its founding in 1995, the company has accelerated the development of top spray and aerosol drug products and has deployed its systems at more than 100 pharmaceutical development and manufacturing sites around the globe. Proveris’s systems are the industry standard and are used by the FDA, CFDA, and the pharmaceutical industry to generate submission-ready data. Proveris is certified to ISO 9001:2015 by TUV Rheinland of North America, Inc., and has more than 20 patents issued on its technology.

About University of Sydney

The University of Sydney is an Australian public research university in Sydney, Australia. Founded in 1850, it is Australia’s first university and is regarded as one of the world’s leading universities. The university is located in Sydney in the southeastern Australian state of New South Wales. In addition to its main location – the Camperdown/Darlington campus – near the city’s central business district, the university has other campuses and research facilities in Sydney and other areas of Australia. One of the additional sites is the One Tree Island Research Station located near the Great Barrier Reef, which facilitates research on topics such as climate change and geology.

About Macquarie University 

Macquarie University is a public research university based in Sydney, Australia, in the suburb of Macquarie Park. Founded in 1964 by the New South Wales Government, it was the third university to be established in the metropolitan area of Sydney. Established as a verdant university, Macquarie has five faculties, as well as the Macquarie University Hospital and the Macquarie Graduate School of Management, which are located on the university’s main campus in suburban Sydney.

Proveris Scientific welcomes back Joseph Werbeck

Proveris Scientific welcomes back Joseph Werbeck as Senior Director to manage its global technical services organization 

Proveris Scientific Corporation, a leading provider of services and technology to advance the science of spray and aerosol products, today announced that it has expanded its technical services organization with the addition of Senior Director of Technical Service, Joseph Werbeck.

Joe will be responsible for managing the Proveris global Technical Services organization and will report to Vice President, Alberto Correia. Joe previously worked for Proveris from 2014 –2018 as Director of Technical Services.  With this experience he is uniquely qualified to drive service activities for exceptional customer satisfaction in the post-global COVID-19 shutdown period.

Joe has more than 20 years of experience in senior technical service, project management, and field engineering roles gained from his time with industry leaders such as: 908 Devices Inc., Seahorse Bioscience (a division of Agilent Technologies), Bruker Daltonics, and ESI Group.

Joe holds a Bachelor of Science, Management degree from University of Phoenix, Associates in Electronics degree from DeVry University, and a Master’s in Project Management from Boston University.

About Proveris Scientific:

Proveris Scientific Corporation advances the science of respiratory drug delivery products by driving new technology development for high performance spray characterization, capture, and analysis, while leveraging its expertise, experience, and core technologies. With customer success as its central motivating force, Proveris Scientific adds value to a global customer base with “complete solutions” which include product innovation, technical services, systems, consumables, and educational training. Since its founding in 1995, the company has accelerated the development of top spray and aerosol drug products and has deployed its systems at more than 100 pharmaceutical development and manufacturing sites around the globe. Proveris’s systems are the industry standard and are used by the FDA, China NMPA (National Medical Products Administration), and the pharmaceutical industry to generate submission-ready data. Proveris is certified to ISO 9001:2015 by TUV Rheinland of North America, Inc., and has more than 20 patents issued on its technology.

Proveris Scientific Expands its Laboratory Services Team

Proveris Scientific Expands its Laboratory Services Team

Proveris Scientific Corporation, a leading provider of services and technology to advance the science of spray and aerosol products, today announced that it has expanded its laboratory services staff by adding Applications Chemist Mohamed Eldam to its team.

Mohammed will provide expert scientific support for customer projects in the GLP/cGMP compliant analytical laboratory, Proveris Laboratories. He will perform contract test services on branded and generic OINDPs (Orally Inhaled and Nasal Drug Products), generate application data, validate customer methods/create new methods, lead investigations of deviations, and implement solutions.

Mohammed has extensive experience working on pre-clinical pharmaceutical research, discovery and product development projects, using/maintaining laboratory equipment (HPLC, FTIR and Gas Chromatography), and managing inventory gained at leading pharmaceutical companies, including Azurity Pharmaceuticals, Eurofins Lancaster Laboratories at Pfizer, Milipore Sigma, and DSM Pharmaceuticals Inc.

Mohammed holds a Bachelor’s degree in Chemistry from Worcester State University.

About Proveris Scientific:

Proveris Scientific Corporation advances the science of respiratory drug delivery products by driving new technology development for high performance spray characterization, capture, and analysis, while leveraging its expertise, experience, and core technologies. With customer success as its central motivating force, Proveris Scientific adds value to a global customer base with “complete solutions” which include product innovation, technical services, systems, consumables, and educational training. Since its founding in 1995, the company has accelerated the development of top spray and aerosol drug products and has deployed its systems at more than 100 pharmaceutical development and manufacturing sites around the globe. Proveris’s systems are the industry standard and are used by the FDA, China NMPA (National Medical Products Administration), and the pharmaceutical industry to generate submission-ready data. Proveris is certified to ISO 9001:2015 by TUV Rheinland of North America, Inc., and has more than 20 patents issued on its technology.

Proveris Scientific announces its laboratory compliance with cGMP

Proveris Scientific announces its laboratory compliance with cGMP (Current Good Manufacturing Practices)

Proveris Scientific Corporation, a leading provider of services and technology to advance the science of spray and aerosol products, today announced it is expanding its contract test services laboratory to allow for compliance with cGMP (current Good Manufacturing Practices). This achievement demonstrates Proveris Scientific’s continued pursuit of excellence and mission to help its customers bring optimally-performing orally inhaled and nasal drug products (OINDP) to patients around the world.

Proveris Scientific’s cGMP compliant laboratory operation will now offer submission grade contract test services, as well as development projects, release testing, and stability studies. Compliance with these practices offers customers assurance that test services performed on their drug products meet the highest of quality standards for regulatory submission. The company will also continue to maintain certification to ISO 9001:2015 for both products and services.

The quality system meets both the FDA and EMA cGMP regulations and guidance documents, ensuring systems are in place covering critical areas. These areas include instrument and system validation, personnel training and monitoring, document controls, and control of processes and facilities. It also includes all guidelines relating to process validation, comprehensive corrective and preventive action (CAPAs), vendor qualification, and best laboratory practices, as well as design and management reviews.

Proveris Scientific is the industry leader in providing spray characterization products and technologies for the OINDP market and are experts in spray and aerosol product evaluation. The company has been manufacturing instruments for over twenty-five years and performing OINDP test services for over fifteen years.

“We are excited to elevate our laboratory from its humble beginnings over 15 years ago as the genesis for countless development projects with our customers around the world to the level required for cGMP compliance. This achievement confirms our commitment and continued investment in the OINDP arena and to accelerating the development efforts we are involved in with our customers around the world,” commented Founder and CEO, Dino J. Farina.

“As a testament to our high standards of excellence, we are proud to add cGMP compliance in our laboratory services offering as another milestone in our history,”

commented President, Chip Leveille. “I am very proud of our team here, who make dedication to quality products, services, and the success of our customers a daily focus. It is a great feat for all of us to see our quality culture culminate into this achievement.”

About Proveris Scientific:

Proveris Scientific Corporation advances the science of respiratory drug delivery products by driving new technology development for high performance spray characterization, capture, and analysis, while leveraging its expertise, experience, and core technologies. With customer success as its central motivating force, Proveris Scientific adds value to a global customer base with “complete solutions” which include product innovation, technical services, systems, consumables, and educational training. Since its founding in 1995, the company has accelerated the development of top spray and aerosol drug products and has deployed its systems at more than 100 pharmaceutical development and manufacturing sites around the globe. Proveris’s systems are the industry standard and are used by the FDA, China NMPA (National Medical Products Administration), and the pharmaceutical industry to generate submission-ready data. The company operates under an ISO 9001:2015 certified quality management system and its laboratory operations are cGMP compliant.

 

Proveris Scientific announces joint scientific poster presentation with H&T Presspart at RDD 2020 Digital Conference

Proveris Scientific announces joint scientific poster presentation with H&T Presspart at RDD 2020 Digital Conference

Proveris Scientific Corporation, a leading provider of services and technology to advance the science of spray and aerosol products, today announced that on April 26 at RDD 2020 Digital Respiratory Drug Delivery Conference, Proveris will present a joint poster with H&T Presspart, Blackburn, Lancashire, UK entitled, “The Effect of Ethanol Concentration on pMDI Evaporation Fraction.”

The subject of the study is introducing a technique to quantify the evaporation fraction using a novel measurement method applied to a time-synchronized image sequence of the aerosol spray from pressurized metered dose inhalers (pMDIs). In order to demonstrate the effectiveness of the technique, the study used non-commercial pMDI product samples with three different ethanol concentrations, but identical devices provided by H&T Presspart. The results show the higher the ethanol concentration, the lower the evaporation fraction.

The FDA May 2019 product specific guidance for beclomethasone dipropionate delivered by MDI lists evaporation rate of the aerosol as an in vitro characterization study that is representative and/or predictive of the clinical effect in the deep lung. Due to the aerosolization mechanism of pMDI products, aerodynamic properties such as evaporation rate impact drug delivery and lung deposition. Currently, there are limited evaporation rate studies and technologies available to effectively study the variable bulk mass of aerosols without interrupting the spray.

The non-impaction laser imaging technology of the well-established Proveris SprayVIEW® measurement system offers meaningful insight into drug product evaporation. The approach is significant as it offers Generic OINDP developers a tool for performing in vitro bioequivalence comparisons between Test and Reference products. 

About Proveris Scientific:

Proveris Scientific Corporation advances the science of respiratory drug delivery products by driving new technology development for high performance spray characterization, capture, and analysis, while leveraging its expertise, experience, and core technologies. With customer success as its central motivating force, Proveris Scientific adds value to a global customer base with “complete solutions” which include product innovation, technical services, systems, consumables, and educational training. Since its founding in 1995, the company has accelerated the development of top spray and aerosol drug products and has deployed its systems at more than 100 pharmaceutical development and manufacturing sites around the globe. Proveris’s systems are the industry standard and are used by the FDA, China NMPA (National Medical Products Administration), and the pharmaceutical industry to generate submission-ready data. Proveris is certified to ISO 9001:2015 by TUV Rheinland of North America, Inc., and has more than 20 patents issued on its technology

About H&T Presspart

H&T Presspart is a pharmaceutical component and device manufacturer for the respiratory drug delivery market, specializing in high-precision injection moulded plastic and deep-drawn metal components. With more than 40 years’ experience, H&T Presspart has a worldwide reputation for competence, quality and innovation in the respiratory drug delivery market. As the healthcare and pharmaceutical sectors continue to evolve, bringing revolutionary drugs to the market, H&T Presspart’s wealth of experience and expertise helps clients in the pharmaceutical industry make the best decisions early in the product and device development process. H&T Presspart’s Inhalation Product Technology Centre (IPTC) supports our customers’ new product developments and strategic initiatives. Founded in 1970 and acquired by the Heitkamp and Thumann group in 2002, H&T Presspart has 3 European manufacturing sites with sales offices around the world.

Lee Dalton joins Proveris as Director of Sales for North America

Lee Dalton joins Proveris as Director of Sales for North America

Proveris Scientific Corporation, a leading provider of services and technology to advance the science of spray and aerosol products, today announced that experienced life sciences professional Lee Dalton has joined Proveris as Director of Sales for North America.

Lee joins Proveris with 25 years of experience in account management, business development, and technical sales at life science technology and instrumentation providers including Biotage AB, Abazyme, SeqLL, LLC, GE Healthcare, Cambridge Biomedical, and Zymark. He has worked throughout the Americas supporting scientists in all laboratory areas with their analytical challenges, from sample preparation and analysis to data analysis reporting. 

“Lee has proven experience and expertise in providing the right instrument and laboratory service solutions to pharmaceutical and biotech companies, from discovery through commercialization. We are confident that Lee will be a strong customer advocate and focus on providing our customers with the highest quality solutions that will enable them to be successful.” said Ben Okorodudu, Vice President of Sales for Proveris.

“I am excited to join the Proveris family at a time when the company is investing in key areas such as R&D and its support team”, said Lee. “I believe that Proveris is a unique company that provides an environment allowing for personal and professional growth through unmatched dedication to quality and customer support.”

About Proveris Scientific

Proveris Scientific Corporation advances the science of respiratory drug delivery products by driving new technology development for high performance spray characterization, capture, and analysis, while leveraging its expertise, experience, and core technologies. With customer success as its central motivating force, Proveris Scientific adds value to a global customer base with “complete solutions” which include product innovation, technical services, systems, consumables, and educational training. Since its founding in 1995, the company has accelerated the development of top spray and aerosol drug products and has deployed its systems at more than 100 pharmaceutical development and manufacturing sites around the globe. Proveris’s systems are the industry standard and are used by the FDA, China NMPA (National Medical Products Administration), and the pharmaceutical industry to generate submission-ready data. Proveris is certified to ISO 9001:2015 by TUV Rheinland of North America, Inc., and has more than 20 patents issued on its technology.